Trial
NCT00254904
Randomized Trial of Gemcitabine/Cisplatin + PF-3512676 vs Gemcitabine/Cisplatin Alone in Patients With Advanced NSCLC
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Pfizer
Collaborators
—
Condition
Carcinoma, Non-Small-Cell Lung
Intervention
Cisplatin
Why stopped
See Termination Reason in Detailed Description
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-03-30